273 related articles for article (PubMed ID: 14737944)
41. Adjuvant concurrent chemoradiation for adenocarcinoma of the distal common bile duct.
Hughes MA; Frassica DA; Yeo CJ; Riall TS; Lillemoe KD; Cameron JL; Donehower RC; Laheru DA; Hruban RH; Abrams RA
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):178-82. PubMed ID: 17276614
[TBL] [Abstract][Full Text] [Related]
42. En bloc vascular resection for locally advanced pancreatic malignancies infiltrating major blood vessels: perioperative outcome and long-term survival in 136 patients.
Yekebas EF; Bogoevski D; Cataldegirmen G; Kunze C; Marx A; Vashist YK; Schurr PG; Liebl L; Thieltges S; Gawad KA; Schneider C; Izbicki JR
Ann Surg; 2008 Feb; 247(2):300-9. PubMed ID: 18216537
[TBL] [Abstract][Full Text] [Related]
43. Dose escalation of concurrent hypofractionated radiotherapy and continuous infusion 5-FU-chemotherapy in advanced adenocarcinoma of the pancreas.
Zimmermann FB; Jeremic B; Lersch C; Geinitz H; Hennig M; Molls M
Hepatogastroenterology; 2005; 52(61):246-50. PubMed ID: 15783041
[TBL] [Abstract][Full Text] [Related]
44. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
Jin J; Liao Z; Zhang Z; Ajani J; Swisher S; Chang JY; Jeter M; Guerrero T; Stevens CW; Vaporciyan A; Putnam J; Walsh G; Smythe R; Roth J; Yao J; Allen P; Cox JD; Komaki R
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):427-36. PubMed ID: 15380576
[TBL] [Abstract][Full Text] [Related]
45. Histopathological response to preoperative chemoradiation for resectable pancreatic adenocarcinoma: the French Phase II FFCD 9704-SFRO Trial.
Le Scodan R; Mornex F; Partensky C; Mercier C; Valette PJ; Ychou M; Roy P; Scoazec JY
Am J Clin Oncol; 2008 Dec; 31(6):545-52. PubMed ID: 19060585
[TBL] [Abstract][Full Text] [Related]
46. Patient profile and treatment outcome of rectal cancer patients treated with multimodality therapy at a regional cancer center.
Deo S; Kumar S; Shukla NK; Kar M; Mohanti BK; Sharma A; Raina V; Rath GK
Indian J Cancer; 2004; 41(3):120-4. PubMed ID: 15472410
[TBL] [Abstract][Full Text] [Related]
47. Survival of patients with advanced non-small-cell lung cancer at Ubon Ratchathani Cancer Center, Thailand.
Srisam-Ang K; Podhipak A; Narksawat K; Supaattagorn P; Tipayamongkholgul M
Southeast Asian J Trop Med Public Health; 2005 Jul; 36(4):994-1006. PubMed ID: 16295558
[TBL] [Abstract][Full Text] [Related]
48. Results of treatment of the adenocarcinoma of the esophagus.
Janssens PJ; Wagener DJ; Nagengast FM; Hoogenraad WJ; Wobbes T; Joosten HJ; Oei SB; van der Steen-Banasik EM
Anticancer Res; 1993; 13(1):209-14. PubMed ID: 7682799
[TBL] [Abstract][Full Text] [Related]
49. Improved survival with adjuvant external-beam radiation therapy in lymph node-negative pancreatic cancer: a United States population-based assessment.
Artinyan A; Hellan M; Mojica-Manosa P; Chen YJ; Pezner R; Ellenhorn JD; Kim J
Cancer; 2008 Jan; 112(1):34-42. PubMed ID: 18000805
[TBL] [Abstract][Full Text] [Related]
50. The treatment of locally advanced pancreatic cancer.
Wagener DJ; de Mulder PH
Anticancer Res; 1989; 9(4):1009-11. PubMed ID: 2683985
[TBL] [Abstract][Full Text] [Related]
51. Aggressive therapy for cancer of the pancreas. Does it help?
Merrick HW; Dobelbower RR
Gastroenterol Clin North Am; 1990 Dec; 19(4):935-62. PubMed ID: 1702757
[TBL] [Abstract][Full Text] [Related]
52. Preoperative chemoradiation and pancreaticoduodenectomy for adenocarcinoma of the pancreas.
Miller AR; Pisters PW; Lee JE; Janjan NA; Abbruzzese JL; Evans DB
Hepatogastroenterology; 1998; 45(21):624-33. PubMed ID: 9684107
[TBL] [Abstract][Full Text] [Related]
53. Pancreatic cancer in Illinois. A report by 88 hospitals on 2,401 patients diagnosed 1978-84.
Sener SF; Fremgen A; Imperato JP; Sylvester J; Chmiel JS
Am Surg; 1991 Aug; 57(8):490-5. PubMed ID: 1928991
[TBL] [Abstract][Full Text] [Related]
54. [Evaluation of curative and palliative treatment of duodenal adenocarcinoma].
Bendixen M; Dahl S; Fristrup C; Mortensen MB
Ugeskr Laeger; 2010 May; 172(18):1376-9. PubMed ID: 20444409
[TBL] [Abstract][Full Text] [Related]
55. [Pancreatic carcinoma: conservative and adjuvant therapy].
Schmassmann A
Ther Umsch; 1996 May; 53(5):387-93. PubMed ID: 8685857
[TBL] [Abstract][Full Text] [Related]
56. [Pancreatic cancer. Treatment and results].
Schlichting E; Graadal O; Aasen AO; Stadaas JO
Tidsskr Nor Laegeforen; 1990 Sep; 110(23):2974-8. PubMed ID: 1700494
[TBL] [Abstract][Full Text] [Related]
57. Prognostic factors in nonresectable pancreatic adenocarcinoma: a rationale to design therapeutic trials.
Cubiella J; Castells A; Fondevila C; Sans M; Sabater L; Navarro S; Fernández-Cruz L
Am J Gastroenterol; 1999 May; 94(5):1271-8. PubMed ID: 10235206
[TBL] [Abstract][Full Text] [Related]
58. Palliative care from the beginning of treatment for advanced pancreatic cancer. Highlights from the "2010 ASCO Gastrointestinal Cancers Symposium". Orlando, FL, USA. January 22-24, 2010.
Lazenby JM; Saif MW
JOP; 2010 Mar; 11(2):154-7. PubMed ID: 20208326
[TBL] [Abstract][Full Text] [Related]
59. Resection for cure of adenocarcinoma of the head of the pancreas: the greater Hartford experience.
Ross HM; Kurtzman SH; Macauly WP; Allen LW; Foster JH; Deckers PJ
Conn Med; 1997 Jan; 61(1):3-7. PubMed ID: 9040155
[TBL] [Abstract][Full Text] [Related]
60. Postresection survival outcomes of pancreatic cancer according to demographic factors and socio-economic status.
Kuhn Y; Koscielny A; Glowka T; Hirner A; Kalff JC; Standop J
Eur J Surg Oncol; 2010 May; 36(5):496-500. PubMed ID: 19748206
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
